STAT+: Maryland state affordability board places a price cap on Ozempic

The Maryland Prescription Drug Affordability Board set a price cap on Ozempic, a diabetes treatment, at $274 for a 30-day supply, expected to save $5.8 million a year. The board aims to lower the cost of the medicine for state and local governments by January 2027. This move is part of the board's efforts to regulate high-cost drugs in Maryland.